77 related articles for article (PubMed ID: 3491886)
1. Test-retest studies of cerebral glucose metabolism using fluorine-18 deoxyglucose: validation of method.
Brooks RA; Di Chiro G; Zukerberg BW; Bairamian D; Larson SM
J Nucl Med; 1987 Jan; 28(1):53-9. PubMed ID: 3491886
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive determination of local cerebral metabolic rate of glucose in man.
Huang SC; Phelps ME; Hoffman EJ; Sideris K; Selin CJ; Kuhl DE
Am J Physiol; 1980 Jan; 238(1):E69-82. PubMed ID: 6965568
[TBL] [Abstract][Full Text] [Related]
3. Cerebral glucose metabolism during pharmacologic studies: test-retest under placebo conditions.
Schmidt ME; Ernst M; Matochik JA; Maisog JM; Pan BS; Zametkin AJ; Potter WZ
J Nucl Med; 1996 Jul; 37(7):1142-9. PubMed ID: 8965185
[TBL] [Abstract][Full Text] [Related]
4. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.
Heiss WD; Pawlik G; Herholz K; Wagner R; Göldner H; Wienhard K
J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929
[TBL] [Abstract][Full Text] [Related]
5. Reproducibility of regional brain metabolic responses to lorazepam.
Wang GJ; Volkow ND; Overall J; Hitzemann RJ; Pappas N; Pascani K; Fowler JS
J Nucl Med; 1996 Oct; 37(10):1609-13. PubMed ID: 8862292
[TBL] [Abstract][Full Text] [Related]
6. Measurements of glucose phosphorylation with FDG and PET are not reduced by dephosphorylation of FDG-6-phosphate.
Kuwabara H; Gjedde A
J Nucl Med; 1991 Apr; 32(4):692-8. PubMed ID: 2013809
[TBL] [Abstract][Full Text] [Related]
7. Glucose metabolic rate kinetic model parameter determination in humans: the lumped constants and rate constants for [18F]fluorodeoxyglucose and [11C]deoxyglucose.
Reivich M; Alavi A; Wolf A; Fowler J; Russell J; Arnett C; MacGregor RR; Shiue CY; Atkins H; Anand A
J Cereb Blood Flow Metab; 1985 Jun; 5(2):179-92. PubMed ID: 3988820
[TBL] [Abstract][Full Text] [Related]
8. Two behavioral states studied in a single PET/FDG procedure: error analysis.
Chang JY; Duara R; Barker W; Apicella A; Yoshii F; Kelley RE; Ginsberg MD; Boothe TE
J Nucl Med; 1989 Jan; 30(1):93-105. PubMed ID: 2783458
[TBL] [Abstract][Full Text] [Related]
9. Mapping of functional activity in brain with 18F-fluoro-deoxyglucose.
Alavi A; Reivich M; Greenberg J; Hand P; Rosenquist A; Rintelmann W; Christman D; Fowler J; Goldman A; MacGregor R; Wolf A
Semin Nucl Med; 1981 Jan; 11(1):24-31. PubMed ID: 6972093
[TBL] [Abstract][Full Text] [Related]
10. Measurement of regional cerebral glucose utilization with fluorine-18-FDG and PET in heterogeneous tissues: theoretical considerations and practical procedure.
Lucignani G; Schmidt KC; Moresco RM; Striano G; Colombo F; Sokoloff L; Fazio F
J Nucl Med; 1993 Mar; 34(3):360-9. PubMed ID: 8441024
[TBL] [Abstract][Full Text] [Related]
11. Quantitative comparison of measurements of cerebral glucose metabolic rate made with two positron cameras.
Grady CL
J Cereb Blood Flow Metab; 1991 Mar; 11(2):A57-63. PubMed ID: 1997489
[TBL] [Abstract][Full Text] [Related]
12. Age differences in intercorrelations between regional cerebral metabolic rates for glucose.
Horwitz B; Duara R; Rapoport SI
Ann Neurol; 1986 Jan; 19(1):60-7. PubMed ID: 3484930
[TBL] [Abstract][Full Text] [Related]
13. Effects of percent thresholding on the extraction of [18F]fluorodeoxyglucose positron emission tomographic region-of-interest data.
Rottenberg DA; Moeller JR; Strother SC; Dhawan V; Sergi ML
J Cereb Blood Flow Metab; 1991 Mar; 11(2):A83-8. PubMed ID: 1997493
[TBL] [Abstract][Full Text] [Related]
14. Quantitative comparison of cerebral glucose metabolic rates from two positron emission tomographs.
Grady CL; Berg G; Carson RE; Daube-Witherspoon ME; Friedland RP; Rapoport SI
J Nucl Med; 1989 Aug; 30(8):1386-92. PubMed ID: 2787850
[TBL] [Abstract][Full Text] [Related]
15. Reproducibility of cerebral glucose metabolic measurements in resting human subjects.
Bartlett EJ; Brodie JD; Wolf AP; Christman DR; Laska E; Meissner M
J Cereb Blood Flow Metab; 1988 Aug; 8(4):502-12. PubMed ID: 3260593
[TBL] [Abstract][Full Text] [Related]
16. Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method.
Schmidt K; Lucignani G; Moresco RM; Rizzo G; Gilardi MC; Messa C; Colombo F; Fazio F; Sokoloff L
J Cereb Blood Flow Metab; 1992 Sep; 12(5):823-34. PubMed ID: 1506447
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET in early infancy: simplified quantification methods to measure cerebral glucose utilization.
Suhonen-Polvi H; Ruotsalainen U; Kinnala A; Bergman J; Haaparanta M; Teräs M; M akel a P; Solin O; Wegelius U
J Nucl Med; 1995 Jul; 36(7):1249-54. PubMed ID: 7790951
[TBL] [Abstract][Full Text] [Related]
18. Effect of gender on glucose utilization rates in healthy humans: a positron emission tomography study.
Miura SA; Schapiro MB; Grady CL; Kumar A; Salerno JA; Kozachuk WE; Wagner E; Rapoport SI; Horwitz B
J Neurosci Res; 1990 Dec; 27(4):500-4. PubMed ID: 2079712
[TBL] [Abstract][Full Text] [Related]
19. What are the sources of error in measuring and calculating cerebral metabolic rates with fluorine-18-fluorodeoxyglucose and PET?
Alavi A; Smith R; Duncan D
J Nucl Med; 1994 Sep; 35(9):1466-70. PubMed ID: 8071693
[No Abstract] [Full Text] [Related]
20. An improved method to calculate cerebral metabolic rates of glucose using PET.
Phillips RL; Chen CY; Wong DF; London ED
J Nucl Med; 1995 Sep; 36(9):1668-79. PubMed ID: 7658230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
